Clinical Trials

Pneumococcal Vaccine

Posted on 6/7/2019
This is a research study to test a vaccine that has not been approved for sale by the FDA.  The vaccine is being studied to protect against pneumococcal disease. The purpose of this study is to test the safety of the study vaccine to see how well the vaccine works when given at the same time as other recommended childhood vaccines. 

Your child would receive either the pneumococcal study vaccine or Prevar 13, which is already approved.  Your child will receive the vaccine at 2, 4, 6, 12 and 15 months of age.  In addition, your child will receive all the other normal vaccinations (RotaTeq, RECOMBIVAX HB, Pentacel, HIBERIX, M-M-R II, VARIVAX, VAQTA)

Your child may be able to join this study if your child is a healthy infant about 2 months old.

Your child will be in the study about 16-20 months and visit the study site about 6 times.

All study visits, procedures and study vaccinations will be provided at no cost to you or your insurance company. 

In addition, you will be compensated for your time and travel if you decide to allow your child participate.  If you and your child complete the study, you will receive up to $510.00.

Call our office for more information - (903) 238-8854
What Our Research Patients are Saying
Being able to participate in the COPD research study has been a life changing event for me.  This is an ongoing positive experience that has already made major differences in my health and the quality of my life. 
 
At the initial interview I was met by a team of friendly, caring, extremely knowledgeable and professional staff.  The high level of care and concern extended to me by the research doctor and everyone involved in this research study is phenomenal.  The research coordinator who I’ve been assigned to is simply “The Best”.  She answers and explains every question I have, she listens when I am having problems with my COPD, and offers helpful suggestions to get me through the rough spots.  She cheers me on when I need it most and follows up with phone calls to make certain I’m ok afterwards.
 
I’m amazed with the positive changes in my health from the first month of my participation. To cough is a rare occurrence where previously it was chronic…all day, every day.   Just walking short distances would render me breathless.  I now can walk longer, do more physically, and breathe much better.  I’m also not so tired all the time.  What a welcome change!
 
I’m happier, less fearful, and more confident in coping with COPD as a result of this research program.  If my participation can contribute to helping others cope with COPD that would be the absolutely ultimate outcome for me.  Thank you for allowing me this opportunity.     
~ S.T.

Contact Form


  
DCOL of Longview